首页> 外国专利> USE OF CRANBERRY DERIVATIVE AND D-MANNOSE COMPOSITION FOR PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS

USE OF CRANBERRY DERIVATIVE AND D-MANNOSE COMPOSITION FOR PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS

机译:蔓越莓衍生物和D-甘露糖成分在预防,控制和改善尿道感染中的用途

摘要

A method is disclosed that prevents, controls and ameliorates urinary tract infections caused by E-coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyandin containing concentrate and D-mannose combined in a form suitable for oral consumption. The cranberry derivative or proanthocyandin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering, a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose and further comprising a diuretic and wherein the composition formed from the cranberry derivative or proanthocyandin containing concentrate, D-mannose and diuretic are effective together for binding to E-coli to aid in flushing the E-coli from the urinary tract system while preventing binding of E-coli to cells in the urinary tract system.
机译:公开了一种方法,该方法通过施用治疗有效量的人类饮食补充剂组合物来预防,预防和改善由大肠杆菌引起的尿路感染,所述人类饮食补充剂组合物包含蔓越莓衍生物或原花青素浓缩物和D-甘露糖,其形式适合口服食用。包含蔓越莓衍生物或原花色素的浓缩物以干重计为约1重量%(1.0%)至约95重量%(95.0%)。该组合物被配制用于递送每剂量约0.5至约5.0克之间的D-甘露糖单位剂量,并且还包含利尿剂,并且其中由蔓越莓衍生物或原花青素浓缩物,D-甘露糖和利尿剂形成的组合物对于结合大肠杆菌,以帮助从尿道系统冲洗大肠杆菌,同时防止大肠杆菌与尿道系统中的细胞结合。

著录项

  • 公开/公告号KR101369538B1

    专利类型

  • 公开/公告日2014-03-04

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20107017857

  • 发明设计人 미나텔리 존;힐 스테판;

    申请日2009-01-09

  • 分类号A61K36/45;A61K31/7004;A61K35/74;A61P13/02;

  • 国家 KR

  • 入库时间 2022-08-21 15:41:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号